Related Experiment Videos
Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen
1Gastrointestinal Research Laboratory, VA Medical Center, San Francisco, CA 94121.
Abstract:
In order to develop reagents that can detect the exposed core carbohydrate antigens of mucins, we have prepared monoclonal antibodies against partially deglycosylated LS174T human colon cancer mucin. The three monoclonal antibodies, 10F4, 15D3a, and 91S8, stained cancers of the colon, pancreas, stomach, breast, prostate, and lung to a greater extent than corresponding normal tissues. There was no staining of normal pancreas or breast, suggesting that these antibodies may be particularly useful for detecting cancers in these two organs. In homogenates of cultured cancer cells, antigen was detectable in three colon cancer cell lines, but not in a variety of other epithelial cancers. The epitope specificity of all three monoclonal antibodies appears to be for Tn antigen, i.e. GalNAc-alpha-Ser/Thr, based on their recognition of alpha-linked GalNAc, but not T antigen, sialyl Tn, or a range of other structures. However, the three anti-Tn antibodies differed in tissue staining specificity and in relative binding to different mucins. These monoclonal antibodies, prepared against deglycosylated colon cancer mucin, appear to be useful reagents for the immunohistochemical detection of epithelial cancers, especially pancreatic cancer and breast cancer.
Insights
Researchers developed novel monoclonal antibodies targeting cancer-specific mucin antigens. These antibodies show promise for detecting various epithelial cancers, particularly pancreatic and breast cancers, via immunohistochemistry.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Mucins are glycoproteins often overexpressed in epithelial cancers.
- Detecting exposed core carbohydrate antigens on mucins can aid cancer diagnosis.
- Development of specific reagents is crucial for accurate cancer detection.
Purpose of the Study:
- To develop monoclonal antibodies for detecting exposed core carbohydrate antigens of mucins.
- To evaluate the utility of these antibodies in immunohistochemical detection of epithelial cancers.
Main Methods:
- Preparation of monoclonal antibodies against partially deglycosylated LS174T human colon cancer mucin.
- Immunohistochemical staining of various cancer and normal tissues using three monoclonal antibodies (10F4, 15D3a, 91S8).
- Epitope mapping to determine antigen specificity (Tn antigen: GalNAc-alpha-Ser/Thr).
Main Results:
- The three monoclonal antibodies stained colon, pancreas, stomach, breast, prostate, and lung cancers more than normal tissues.
- No staining was observed in normal pancreas or breast tissue, indicating high specificity.
- Antigen was detected in colon cancer cell lines but not in other tested epithelial cancers.
- Antibodies recognized the Tn antigen (GalNAc-alpha-Ser/Thr) but not T antigen or sialyl Tn.
Conclusions:
- The developed anti-Tn monoclonal antibodies are valuable reagents for immunohistochemical detection of epithelial cancers.
- These antibodies show particular potential for detecting pancreatic and breast cancers due to specific staining patterns.
- Differences in tissue staining and mucin binding among the antibodies suggest distinct specificities within the anti-Tn category.